4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001127602-23-025164
CIK 0001878313other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:14 PM ET
Size
5.1 KB
Accession
0001127602-23-025164
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2023-09-30+8,378→ 8,378 totalExercise: $2.20From: 2023-09-30Exp: 2033-09-30→ Common Stock (8,378 underlying)
Footnotes (1)
- [F1]The stock options, granted on September 30, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:14 PM ET
- Size
- 5.1 KB